4uw1
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='4uw1' size='340' side='right'caption='[[4uw1]], [[Resolution|resolution]] 3.37Å' scene=''> | <StructureSection load='4uw1' size='340' side='right'caption='[[4uw1]], [[Resolution|resolution]] 3.37Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4uw1]] is a 8 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4uw1]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UW1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UW1 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=92R:3-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-5-METHOXYISOQUINOLIN-1(2H)-ONE'>92R</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=92R:3-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-5-METHOXYISOQUINOLIN-1(2H)-ONE'>92R</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4uw1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uw1 OCA], [https://pdbe.org/4uw1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4uw1 RCSB], [https://www.ebi.ac.uk/pdbsum/4uw1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4uw1 ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/TNKS1_HUMAN TNKS1_HUMAN] Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking. Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation (PARsylation) of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP-ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation. Also mediates PARsylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination. Mediates PARsylation of TERF1, thereby contributing to the regulation of telomere length. Involved in centrosome maturation during prometaphase by mediating PARsylation of HEPACAM2/MIKI. May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles. May be involved in spindle pole assembly through PARsylation of NUMA1.<ref>PMID:10988299</ref> <ref>PMID:11739745</ref> <ref>PMID:16076287</ref> <ref>PMID:19759537</ref> <ref>PMID:21478859</ref> <ref>PMID:22864114</ref> |
==See Also== | ==See Also== | ||
- | *[[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase]] | + | *[[Poly(ADP-ribose) polymerase 3D structures|Poly(ADP-ribose) polymerase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Oliver | + | [[Category: Oliver AW]] |
- | [[Category: Pearl | + | [[Category: Pearl LH]] |
- | [[Category: Rajasekaran | + | [[Category: Rajasekaran MB]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 07:44, 29 March 2023
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor
|